Catecholamines and schizophrenia : [proceedings of the third international Symposium on Catecholamines, Strasbourg, France, May 18-21, 1973] /

Catecholamines and Schizophrenia reviews research linking catecholamines to schizophrenia. Topics include the relationship between stereotyped behavior and amphetamine psychosis, between antipsychotic drugs and catecholamine synapses, and between biogenic amines and behavior. The chemical neuropatho...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Symposium on Catecholamines Strasbourg, France
Otros Autores: Matthysse, Steven (Editor ), Kety, Seymour S. (Editor )
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Oxford : Pergamon Press, 1975.
Edición:First edition.
Temas:
Schizophrenia > Congresses.
Catecholamines > Congresses.
Catecholamines.
Schizophrenia.
Catecholamines
Schizophrenia
Schizophr�enie > Congr�es.
Cat�echolamines > Congr�es.
Cat�echolamines.
Schizophr�enie.
HEALTH & FITNESS > Diseases > General.
MEDICAL > Clinical Medicine.
MEDICAL > Diseases.
MEDICAL > Evidence-Based Medicine.
MEDICAL > Internal Medicine.
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congr�es.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover; Catecholamines and Schizophrenia; Copyright Page; ACKNOWLEDGEMENTS; Table of Contents; PROLOGUE; EPILOGUE; CONTRIBUTORS; Chapter 1. PHARMACOLOGY AND PHYSIOLOGY OF STEREOTYPED BEHAVIOR; PSYCHOLOGY OF STEREOTYPED BEHAVIOR; BRAIN DOPAMINE AND STEREOTYPED BEHAVIOR; RELATION OF STEREOTYPED BEHAVIOR AND BRAIN DOPAMINE TO SCHIZOPHRENIA, MANIA AND DEPRESSION; REFERENCES; DISCUSSION; Chapter 2. AMPHETAMINE PSYCHOSIS: BEHAVIORAL AND BIOCHEMICAL ASPECTS; INTRODUCTION; BEHAVIORAL ASPECTS-HOSPITALIZED CASES; BEHAVIORAL ASPECTS-EXPERIMENTALLY-INDUCED CASES; BIOCHEMICAL ASPECTS
  • CATECHOLAMINE METABOLITES IN CEREBROSPINAL FLUID AFTER AMPHETAMINE ADMINISTRATIONBEHAVIOURAL AND BIOCHEMICAL EFFECTS OF l-DOPA ADMINISTRATION IN PSYCHIATRIC PATIENTS; ANTAGONISM OF AMPHETAMINE-INDUCED SYMPTOMS BY HALOPERIDOL; CONCLUSION; REFERENCES; Chapter 3. A TWO FACTOR THEORY OF SCHIZOPHRENIA; DISCUSSION; REFERENCES; Chapter 4. STEREOSELECTIVE FEATURES OF CATECHOLAMINE DISPOSTION AND THEIR BEHAVIORAL IMPLICATIONS; BIOCHEMICAL STUDIES OF STEREOSELECTIVE CATECHOLAMINE DISPOSITION; BEHAVIORAL IMPLICATIONS; SUMMARY; REFERENCES
  • Chapter 8. DOSE EQUIVALENCE OF THE ANTIPSYCHOTIC DRUGSREFERENCES; BRIEF COMMUNICATIONS; Chapter 9. MASS FRAGMENTOMETRIC DETERMINATION OF HOMOVANILLIC ACID IN LUMBAR CEREBROSPINAL FLUID OF SCHIZOPHRENICPATIENTS DURING TREATMENTWITH ANTIPSYCHOTIC DRUGS; REFERENCES; Chapter 10. NEW DEVELOPMENTS IN THE STUDY OF THE MECHANISM OF ACTION OF NEUROLEPTICS AND AMPHETAMINE; 1. CORTICAL DOPAMINERGIC TERMINALS; 2. DECREASED SYNTHESIS OF DOPAMINE IN THE NEOSTRIATUM OF THE RAT AFTER A REPEATED TREATMENT WITH A NEUROLEPTIC; 3. STUDIES ON DOPAMINE RELEASE IN A CHRONIC MONKEY PREPARATION; REFERENCES

Ejemplares similares